pharm4all
Enter subtitle here
Of all of the generic medications available in exactly the exact same generic category, how can the pharmacist pick the one that he suggests? In practice, pharmacists store just a limited variety of generic medications, typically three or two, for every generic category. Its choice criteria for its inventory are multiple: cost, look, size, presentation, flavor of this medication, colour and form of their packaging, commercial connections with these and such a supplier, etc.. It's all up to him to accommodate his choice into the fantasies and expectations of his clientele. Whatever the case, all need to honor a very simple rule, specifically for long-term and older treatment: always supply the identical generic name to be able to ease the identification and appropriate use of the drug by the individual. The marketing authorization that enables the promotion of a generic medicinal product relies on the efficacy and safety data obtained using the original medicinal product. Clinical studies to verify this efficacy are consequently not essential. But since the shape and the excipients contained in the generic medications aren't always equal to those of the original medicinal solution, studies have been carried out to make sure that the generic drug is consumed and then removed under identical or quite similar states of the initial drug. This cost difference can vary from 40 to 50 percent for the latest generic medications. It's explained by the very substantial costs of development and research that precede the advertising of a new medication, which labs pass about the selling costs of their initial medication. These prices don't exist for generic producers, which lets them create precisely the very same principles at a lower cost. This cost difference isn't systematic, but since a number of the first drugs have reduced their costs to compete with generic medications. Together with the consequence of many samples, it's assessed whether the generic medication is consumed in precisely the exact same manner as the initial medication. It's necessary to see that both of these components are just a part of bio-equivalence criteria. Additionally, the "80 percent to 125 percent rule" applies for many brand or generic drugs.